Global markets are ending a turbulent first quarter. War in Iran has significantly impacted stocks and energy prices. Investors are bracing for more volatility with upcoming U.S. jobs data and South Korean trade figures. Euro zone inflation is also expected to rise, potentially pressuring the European Central Bank. The coming week promises crucial economic indicators and continued market uncertainty.Read More
India’s metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With significant price drops and increased launches, demand is surging among millions needing obesity management. Broader specialist adoption and a growing prescriber base are fueling this expansion, promising substantial market growth.Read More
Specialised equipment maker Kay Bouvet Engineering’s Rs 1,000 crore debt is poised for takeover by NARCL. Banks will see a 13% recovery through NARCL’s Rs 130 crore offer, which faced no competition in a Swiss challenge auction. This marks a potential final acquisition for the bad loan aggregator this fiscal year.Read More
India’s Nifty index shows resilience against potential oil price surges from the Gulf conflict. Companies within the Nifty that supply energy like coal and electricity stand to gain. Demand for these energy sources is expected to rise as alternatives to oil and gas. Conversely, smaller companies face greater impact from rising fuel costs.Read More
U.S. stocks plunged Friday, with major indexes hitting seven-month lows as a Middle East war continued to suppress risk appetite. The Dow entered correction territory, down over 10% from its record high. Rising oil prices fueled inflation fears, dampening hopes for Fed rate cuts.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
